Fosun Adgenvax Overview
- Year Founded
-
2012
- Status
-
IPO Registration
- Employees
-
700
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
6
Fosun Adgenvax General Information
Description
Developer of preventative vaccines designed to address infectious diseases including rabies, influenza, pneumococcal disease, and meningococcal disease. The company develops multivalent conjugate vaccines, recombinant vaccines using insect cell lines, and inactivated and attenuated vaccines, enabling healthcare providers to prevent the spread of viral and bacterial infections across diverse patient populations.
Contact Information
Website
www.adgenvax.comCorporate Office
- Number 550, Fenghuang Road
- Shuangliu District
- Chengdu, Sichuan 610129
- China
Corporate Office
- Number 550, Fenghuang Road
- Shuangliu District
- Chengdu, Sichuan 610129
- China
Fosun Adgenvax Timeline
Fosun Adgenvax Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. IPO | 26-Jun-2026 | Announced | Generating Revenue | |||
| 7. Later Stage VC (Series B) | 24-Jun-2026 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 11-Oct-2024 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 27-Aug-2024 | Completed | Generating Revenue | |||
| 4. Merger/Acquisition | 28-Oct-2021 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 28-Oct-2021 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 01-Apr-2019 | $44.7M | $59.7M | Completed | Generating Revenue | |
| 1. Early Stage VC | 10-Aug-2016 | $15M | $15M | Completed | Generating Revenue |
Fosun Adgenvax Signals
Fosun Adgenvax Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Chengdu Bio-Town Investment | Government | Minority | ||
| China Resources Capital Management | Corporate Venture Capital | Minority | ||
| Fosun Pharma | Corporation | Minority | ||
| Guangzhou Yuexiu Industrial Investment Fund Management | PE/Buyout | Minority | ||
| Prosperico Ventures | Venture Capital | Minority |
Fosun Adgenvax FAQs
-
When was Fosun Adgenvax founded?
Fosun Adgenvax was founded in 2012.
-
Where is Fosun Adgenvax headquartered?
Fosun Adgenvax is headquartered in Chengdu, China.
-
What is the size of Fosun Adgenvax?
Fosun Adgenvax has 700 total employees.
-
What industry is Fosun Adgenvax in?
Fosun Adgenvax’s primary industry is Pharmaceuticals.
-
Is Fosun Adgenvax a private or public company?
Fosun Adgenvax is a Private company.
-
What is Fosun Adgenvax’s current revenue?
The current revenue for Fosun Adgenvax is .
-
How much funding has Fosun Adgenvax raised over time?
Fosun Adgenvax has raised $143M.
-
Who are Fosun Adgenvax’s investors?
Chengdu Bio-Town Investment, China Resources Capital Management, Fosun Pharma, Guangzhou Yuexiu Industrial Investment Fund Management, and Prosperico Ventures are 5 of 6 investors who have invested in Fosun Adgenvax.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process